Overview
- IndustryPharmaceutical Preparations1
- HeadquartersHeilongjiang Province, China1
- Business address3199-1 Longxiang Road, Songbei District, Harbin City, Heilongjiang Province, F4 1500283
- Filer categoryNon-accelerated filer, Smaller reporting company3
See how the biggest companies compare on our leaderboards
Universal Fog, Inc. (which has been in continuous operation since 1996) became a wholly-owned subsidiary of Edmonds 6.4 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2023
Where the money goes
Where each dollar of revenue went, fiscal 2023
- Cost of revenue8¢$111.4K
- Selling, general and admin92¢$1.3M
Out of $111.6K in revenue.2 The company lost money this year.
Financial statements
| Fiscal year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $7.8M5 | $6.4M6 | $6.6M7 | $9.3M8 | $9.9M9 | $6.5M10 | $2672 | $111.6K2 |
| Cost of revenue | $5.5M5 | $4.1M6 | $4.3M7 | $2.2M8 | $2.7M9 | $2.9M10 | $1.7K2 | $111.4K2 |
| Gross profit | $2.3M5 | $2.3M6 | $2.3M7 | $7.0M8 | $7.3M9 | $3.6M10 | -$1.5K2 | $2202 |
| Research and development | ||||||||
| Selling, general and admin | $2.0M5 | $1.8M6 | $2.2M7 | $1.9M8 | $1.8M9 | $1.2M10 | $934.9K2 | $1.3M2 |
| Operating expenses | $1.6M2 | $1.8M2 | ||||||
| Operating income | -$281.0K5 | -$167.5K6 | -$466.9K7 | $4.6M8 | $4.9M9 | $1.9M10 | -$1.6M2 | -$1.8M2 |
| Interest | $102.3K5 | $159.9K6 | $49.4K7 | $68 | $19 | |||
| Income before tax | -$351.0K2 | -$408.8K2 | ||||||
| Income tax | $344.0K5 | $458.1K6 | $263.1K7 | $1.4M8 | $1.5M9 | $730.5K10 | $2.9K2 | |
| Net income | $159.6K5 | $1.3M6 | -$316.8K7 | $3.3M8 | $3.6M9 | $1.3M10 | -$353.9K2 | -$408.8K2 |
| Earnings per share | $0.0210 | -$0.012 | -$0.012 | |||||
| Earnings per share (diluted) | $0.0210 | -$0.012 | -$0.012 | |||||
| Shares (weighted, basic) | 65.5M shares2 | 65.5M shares2 | ||||||
| Shares (weighted, diluted) | 65.5M shares2 | 65.5M shares2 |
| Fiscal year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| Cash | $29.8M6 | $21.2M7 | $32.6M8 | $35.5M9 | $36.1M9 | $44.3M10 | $44.8M2 | $47.2K2 |
| Receivables | $9.6K2 | |||||||
| Inventory | $521.2K2 | $40.6K2 | ||||||
| Current assets | $31.5M5 | $33.5M6 | $34.7M7 | $38.4M8 | $41.8M9 | $47.7M10 | $45.6M2 | $41.0M2 |
| Property, plant and equipment | $3.2M2 | $2.7M2 | ||||||
| Intangible assets | $1.4M2 | $964.8K2 | ||||||
| Total assets | $40.3M5 | $41.7M6 | $42.9M7 | $45.8M8 | $48.2M9 | $53.9M10 | $50.7M2 | $45.1M2 |
| Current liabilities | $6.0M5 | $7.0M6 | $7.7M7 | $8.6M8 | $8.6M9 | $9.1M10 | $7.9M2 | $6.0M2 |
| Retained earnings | $41.7M2 | $41.3M2 | ||||||
| Shareholders’ equity | $34.2M6 | $34.7M7 | $35.2M8 | $37.2M9 | $39.7M10 | $44.8M10 | $42.8M2 | $39.1M2 |
| Shares outstanding | 65.8M shares14 | 65.5M shares5 | 65.5M shares6 | 65.5M shares7 | 65.5M shares8 | 65.5M shares9 | 65.5M shares10 | 65.5M shares2 |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Compare China Health Industries Holdings, Inc. with another company
What it owns
What China Health Industries Holdings, Inc. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Property and equipment
| Item | Latest | A year before | Change |
|---|---|---|---|
| Construction in progress | $420.1K2 Jun 30, 2023 | $579.4K2 Jun 30, 2022 | −27.5% |
| Accumulated depreciation | $3.8M2 Jun 30, 2023 | $3.9M2 Jun 30, 2022 | −2.8% |
| Property and equipment, net | $2.7M2 Jun 30, 2023 | $3.2M2 Jun 30, 2022 | −13.6% |
Investments
| Item | Latest | A year before | Change |
|---|---|---|---|
| Cash and cash equivalents | $47.2K2 Jun 30, 2023 | $44.8M2 Jun 30, 2022 | −99.9% |
Intangibles and goodwill
| Item | Latest | A year before | Change |
|---|---|---|---|
| Intangible assets, net (excluding goodwill) | $964.8K2 Jun 30, 2023 | $1.4M2 Jun 30, 2022 | −31.7% |
| Accumulated amortization | -$5.0M2 Jun 30, 2023 | -$5.1M2 Jun 30, 2022 | +0.9% |
| Finite-lived intangibles, net | $964.8K2 Jun 30, 2023 | $1.4M2 Jun 30, 2022 | −31.7% |
Inventory
Leadership
Who has led China Health Industries Holdings, Inc., and when. Pick a name to see everywhere that person has worked.
Chief executive
Chair
Chief financial officer
Former names
Timeline
- Sep 13, 20248-K Change of auditor18
- Jul 17, 20248-K Entered a material agreement; Completed an acquisition or sale19
- May 16, 20248-K Financial statements and exhibits20
- Dec 4, 20238-K Completed an acquisition or sale21
- Oct 24, 20238-K Change of auditor22
- Aug 4, 20238-K Change of auditor23
- Jul 3, 20238-K Entered a material agreement24
- Apr 7, 2009New chief executive Sun Xin becomes CEO15
Filings
40 filings to the SEC since October 2021: 4 annual reports, 9 quarterly reports, 7 major events, 20 other. The latest 20:
- Feb 14, 2025NT 10-Q NOTIFICATION OF LATE FILING EDGAR
- Nov 14, 2024NT 10-Q NOTIFICATION OF LATE FILING EDGAR
- Sep 30, 2024NT 10-K NOTIFICATION OF LATE FILING EDGAR
- Sep 13, 20248-K CURRENT REPORT EDGAR
- Jul 17, 20248-K CURRENT REPORT EDGAR
- Jun 26, 202410-Q QUARTERLY REPORT EDGAR
- May 16, 20248-K/A AMENDMENT NO. 1 TO FORM 8-K EDGAR
- May 15, 2024NT 10-Q NOTIFICATION OF LATE FILING EDGAR
- Apr 1, 202410-Q QUARTERLY REPORT EDGAR
- Feb 15, 2024NT 10-Q NOTIFICATION OF LATE FILING EDGAR
- Jan 23, 2024UPLOAD EDGAR
- Jan 19, 2024CORRESP EDGAR
- Jan 9, 2024UPLOAD EDGAR
- Jan 8, 2024SPDSCL EDGAR
- Jan 8, 2024CORRESP EDGAR
- Dec 27, 2023UPLOAD EDGAR
- Dec 4, 20238-K CURRENT REPORT EDGAR
- Nov 21, 202310-Q QUARTERLY REPORT EDGAR
- Nov 15, 2023NT 10-Q NOTIFICATION OF LATE FILING EDGAR
- Nov 13, 202310-K ANNUAL REPORT EDGAR
The 40 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
SEC filer profile
How China Health Industries Holdings, Inc. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGARChina Health Industries Holdings, Inc.1
- CIK0001309057
- Employer ID (EIN)86-08272161
- Filer statusNon-accelerated filer<br>smaller reporting company1
- Fiscal year endsJune 301
- Industry code (SIC)2834 Pharmaceutical Preparations1
- SEC reviewing officeOffice of Life Sciences, Division of Corporation Finance1
- Business address3199-1 Longxiang Road, Songbei District, Harbin City, Heilongjiang Province, F4 1500281
- Phone011-86-451-517194071
- Shares outstanding65,539,737 as of Jun 26, 202413
- Public float$7.7M as of Dec 31, 20222
- On EDGAR sinceDec 1, 20041
- Filings263 in all: 10-Q (47), 8-K (31), UPLOAD (31), CORRESP (25), 10-K (14), 8-K/A (12), 10-K/A (10), 10QSB (10)1
All 28 form types
NT 10-Q (10), NT 10-K (9), PRER14C (9), 10KSB/A (8), 10QSB/A (8), 3 (8), SB-2/A (8), 4 (4), 10-Q/A (3), 10KSB (3), DEF 14C (2), EFFECT (2), PRE 14C (2), 10SB12G (1), POS AM (1), RW (1), S-8 (1), SB-2 (1), SC 13D (1), SPDSCL (1)
- Latest filingsAnnual report (10-K) Nov 13, 2023
Quarterly report (10-Q) Jun 26, 2024
Latest 8-K (8-K) Sep 13, 2024
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15SEC EDGARSun Xin, Chief executive officer
- 16SEC EDGARSun Xin, Chair
- 17SEC EDGARSun Xin, Board member
- 18SEC EDGARChange of auditor
- 19
- 20SEC EDGARFinancial statements and exhibits
- 21SEC EDGARCompleted an acquisition or sale
- 22SEC EDGARChange of auditor
- 23SEC EDGARChange of auditor
- 24SEC EDGAREntered a material agreement